Related references
Note: Only part of the references are listed.Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis
Stephanie Taha-Mehlitz et al.
THERANOSTICS (2021)
Combined burden and functional impact tests for cancer driver discovery using DriverPower
Shimin Shuai et al.
NATURE COMMUNICATIONS (2020)
Multiomic Integration of Public Oncology Databases in Bioconductor
Marcel Ramos et al.
JCO CLINICAL CANCER INFORMATICS (2020)
A compendium of mutational cancer driver genes
Francisco Martinez-Jimenez et al.
NATURE REVIEWS CANCER (2020)
Next-generation characterization of the Cancer Cell Line Encyclopedia
Mahmoud Ghandi et al.
NATURE (2019)
The landscape of cancer cell line metabolism
Haoxin Li et al.
NATURE MEDICINE (2019)
OncodriveCLUSTL: a sequence-based clustering method to identify cancer drivers (vol 35, pg 5396, 2019)
Claudia Arnedo-Pac et al.
BIOINFORMATICS (2019)
Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients
Ilya G. Serebriiskii et al.
NATURE COMMUNICATIONS (2019)
LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function
Fengyuan Tang et al.
NATURE COMMUNICATIONS (2019)
Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities
Philamer C. Calses et al.
TRENDS IN CANCER (2019)
Network-based integration of multi-omics data for prioritizing cancer genes
Christos Dimitrakopoulos et al.
BIOINFORMATICS (2018)
Targeting LGR5 in Colorectal Cancer: therapeutic gold or too plastic?
R. G. Morgan et al.
BRITISH JOURNAL OF CANCER (2018)
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics
Li Ding et al.
CELL (2018)
Comprehensive Characterization of Cancer Driver Genes and Mutations
Matthew H. Bailey et al.
CELL (2018)
Universal Patterns of Selection in Cancer and Somatic Tissues (vol 171, pg 1029, 2017)
Inigo Martincorena et al.
CELL (2018)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin
Touko Inao et al.
Oncotarget (2018)
Identification and characterization of a novel adenomatous polyposis coli mutation in adult pancreatoblastoma
Shigeo Yamaguchi et al.
Oncotarget (2018)
Therapeutic Ablation of Gain-of-Function Mutant p53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and Invasion
Ramona Schulz-Heddergott et al.
CANCER CELL (2018)
Comprehensive Characterization of Cancer Driver Genes and Mutations (vol 173, 371.e1, 2018)
Matthew H. Bailey et al.
CELL (2018)
Mutational processes shape the landscape of TP53 mutations in human cancer
Andrew O. Giacomelli et al.
NATURE GENETICS (2018)
Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration
James M. McFarland et al.
NATURE COMMUNICATIONS (2018)
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
Yumeng Wang et al.
CELL REPORTS (2018)
The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers
Zbyslaw Sondka et al.
NATURE REVIEWS CANCER (2018)
Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells
Robin M. Meyers et al.
NATURE GENETICS (2017)
Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data
Subarna Sinha et al.
NATURE COMMUNICATIONS (2017)
3D clusters of somatic mutations in cancer reveal numerous rare mutations as functional targets
Jianjiong Gao et al.
GENOME MEDICINE (2017)
The Rac GTPase in Cancer: From Old Concepts to New Paradigms
Marcelo G. Kazanietz et al.
CANCER RESEARCH (2017)
Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening
E. Robert McDonald et al.
CELL (2017)
Defining a Cancer Dependency Map
Aviad Tsherniak et al.
CELL (2017)
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity
Matthew T. Chang et al.
NATURE BIOTECHNOLOGY (2016)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance
Richard Marcotte et al.
CELL (2016)
A Landscape of Pharmacogenomic Interactions in Cancer
Francesco Iorio et al.
CELL (2016)
Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines
Nesstor Pilco-Ferreto et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Amplification of TLK2 Induces Genomic Instability via Impairing the G2-M Checkpoint
Jin-Ah Kim et al.
MOLECULAR CANCER RESEARCH (2016)
Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers
Jin-Ah Kim et al.
NATURE COMMUNICATIONS (2016)
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
Andrew J. Aguirre et al.
CANCER DISCOVERY (2016)
HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models1
Mariacarla Andreozzi et al.
NEOPLASIA (2016)
Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations
Turgut Dogruluk et al.
CANCER RESEARCH (2015)
WEE1 Kinase As a Target for Cancer Therapy
Sabine Mueller et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
gespeR: a statistical model for deconvoluting off-target-confounded RNA interference screens
Fabian Schmich et al.
GENOME BIOLOGY (2015)
Predicting Cancer-Specific Vulnerability via Data-Driven Detection of Synthetic Lethality
Livnat Jerby-Arnon et al.
CELL (2014)
YAP activation is an early event and a potential therapeutic target in liver cancer development
Andrea Perra et al.
JOURNAL OF HEPATOLOGY (2014)
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence et al.
NATURE (2014)
Mining TCGA Data Using Boolean Implications
Subarna Sinha et al.
PLOS ONE (2014)
Cyclin-dependent kinases
Marcos Malumbres
GENOME BIOLOGY (2014)
Finding the active genes in deep RNA-seq gene expression studies
Traver Hart et al.
BMC GENOMICS (2013)
Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling
Guobin He et al.
CELL (2013)
ATARiS: Computational quantification of gene suppression phenotypes from multisample RNAi screens
Diane D. Shao et al.
GENOME RESEARCH (2013)
Synthetic sickness or lethality points at candidate combination therapy targets in glioblastoma
Ewa Szczurek et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets
O. A. Kent et al.
ONCOGENE (2013)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Essential Gene Profiles in Breast, Pancreatic, and Ovarian Cancer Cells
Richard Marcotte et al.
CANCER DISCOVERY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Germline KRAS Mutations Cause Aberrant Biochemical and Physical Properties Leading to Developmental Disorders
Lothar Gremer et al.
HUMAN MUTATION (2011)
LRRC4 Inhibits the Proliferation of Human Glioma Cells by Modulating the Expression of STMN1 and Microtubule Polymerization
Rong Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Human SBK1 is dysregulated in multiple cancers and promotes survival of ovary cancer SK-OV-3 cells
Pingzhang Wang et al.
MOLECULAR BIOLOGY REPORTS (2011)
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer
Hiu Wing Cheung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
Craig H. Mermel et al.
GENOME BIOLOGY (2011)
Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy
Tatsuhiro Shibata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Experimental validation of the importance of seed complement frequency to siRNA specificity
Emily M. Anderson et al.
RNA (2008)
Boolean implication networks derived from large scale, whole genome microarray datasets
Debashis Sahoo et al.
GENOME BIOLOGY (2008)
Comprehensive analysis of oncogenic effects of PIK3CA mutations in human mammary epithelial cells
Haijun Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes
P. M. Pollock et al.
ONCOGENE (2007)
A probability-based approach for the analysis of large-scale RNAi screens
Renate Koenig et al.
NATURE METHODS (2007)
A census of mitotic cancer genes:: new insights into tumor cell biology and cancer therapy
Ignacio Perez de Castro et al.
CARCINOGENESIS (2007)
Interleukin-6 gene amplification and shortened survival in glioblastoma patients
A. Tchirkov et al.
BRITISH JOURNAL OF CANCER (2007)
Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation
Silvia Di Agostino et al.
CANCER CELL (2006)
LRRC4, a putative tumor suppressor gene, requires a functional leucine-rich repeat cassette domain to inhibit proliferation of glioma cells in vitro by modulating the extracellular signal-regulated kinase/protein kinase B/nuclear factor-κB pathway
Minghua Wu et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Position-specific chemical modification of siRNAs reduces off-target'' transcript silencing
Aimee L. Jackson et al.
RNA (2006)
3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets
A Birmingham et al.
NATURE METHODS (2006)
Inactivation of Crk SH3 domain-binding guanine nucleotide-releasing factor (C3G) in cervical squamous cell carcinoma
K Okino et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Study of a novel brain relatively specific gene LRRC4 involved in glioma tumorigenesis suppression using the Tet-on system
QH Zhang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2005)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain
C Gaiddon et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Share Paper
